PMWC - Program

January 22

	Track 1	Track 2	Track 3	Track 4	Track 5	Track 6	Track 7
January 22
Jan. 22 8:00 A.M.	Registration and Networking
Jan. 22 9:00 A.M.	Fireside Chat 1 - Immunotherapy Theresa LaVallee Ph.D., VP, Translational Medicine & Regulatory Affairs, Parker Inst.Parker Inst.	Fireside Chat 1 - AI/ML Data Sciences Chair: Michael Pellini M.D., M.B.A, Managing Partner, Section 32Section 32 Brook Byers Founder & Partner, Kleiner PerkinsKleiner Perkins	Successful Genomics Programs – Research and Clinical \| Panel Chair: Clara Lajonchere Ph.D., Deputy Dir., UCLA Inst. for Prec. HealthUCLA	The Evolving Landscape of Clinical Molecular Testing in Oncology Chair: Anna Berry M.D., Dir. for Molecular Pathology & Genomics, Swedish CancerSwedish Cancer	Fireside Chat- Health Data Chair: Jay Bhattacharya M.D., Ph.D., Prof. of Medicine, Stanford U.Stanford	NCI Showcase Keynote Xing-Jian Lou Ph.D., Program Dir., NCINIH NCI	AI and Data Sciences Showcase Eric Little Ph.D., CEO, LeapAnalysisLeapAnalysis
Jan. 22 9:15 A.M.	Fireside Chat 1 - Immunotherapy Philip Greenberg M.D., Head, Program in Immunology, Fred HutchFred Hutch	Fireside Chat 1 - AI/ML Data Sciences Vijay Pande Ph.D., General Partner, Andreessen HorowitzAndreessen Horowitz	Successful Genomics Programs – Research and Clinical \| Panel Steven Smith M.D., SVP & CSO, Research Inst. Orlando, AdventHealthAdventHealth	Adoption of Molecular Profiling in the Clinical Setting \| Panel Chair: Anne-Renee Hartman M.D., Biotech Executive & AdvisorAdvisor	Fireside Chat- Health Data Peter Thiel J.D., Investor & EntrepreneurInvestor & Entrepreneur	NCI Showcase Siyang Zheng Ph.D., Prof., CMU.; Founder, Captis DiagnosticsCaptis Diagnostics	AI and Data Sciences Showcase Carla R Leibowitz Chief BD Officer, Paige.AIPaigeAI
Jan. 22 9:30 A.M.	Fireside Chat 2 - Immunotherapy Chair: Harlan Robins Ph.D., CSO & Co-Founder, Adaptive BiotechAdaptive Biotech	Fireside Chat 2 - Practicing Safe, Fair and Responsible Data Analytics & AI, in the Modern Patient Data Ecosystem Chair: Atul Butte M.D., Ph.D., Dir., Bakar. Inst., UCSFUCSF	Successful Genomics Programs – Research and Clinical \| Panel Debra GB Leonard M.D., Ph.D., Chair & Prof., U. of Vermont Health NetworkU. of Vermont Health Network Chris Lunt Chief Technology Officer, AllofUs Research ProgramAllofUs Research Program	Adoption of Molecular Profiling in the Clinical Setting \| Panel Cassie Hajek M.D., Chair & Medical Dir., Sanford ImageneticsSanford Imagenetics	Health Data-Making PM Mainstream Keynote Michael Snyder Ph.D., Prof. & Chair, Stanford Ctr. of Genomics & PMStanford (SCGPM)	NCI Showcase Jeremy Norris Ph.D., Co-Founder, CEO, Frontier DiagnosticsFrontier Diagnostics	AI and Data Sciences Showcase Jarret Glasscock Ph.D., CEO, Cofactor GenomicsCofactor Genomics
Jan. 22 9:45 A.M.	Fireside Chat 2 - Immunotherapy Ira Mellman Ph.D., VP, Cancer Immunology, GenentechGenentech	Fireside Chat 2 - Practicing Safe, Fair and Responsible Data Analytics & AI, in the Modern Patient Data Ecosystem Cora Han Chief Health Data Officer, UC HealthUC Health	Successful Genomics Programs – Research and Clinical \| Panel Anthony D Slonim M.D., Pres. & CEO, Renown HealthRenown Health Euan Ashley Ph.D., Dir., Stanford Clinical Genomics ServiceStanford	Adoption of Molecular Profiling in the Clinical Setting \| Panel Peter Hulick M.D., FACMG, Medical Dir., Ctr. for PM, NorthShore U. HealthSystemNorthShore U. HealthSystem Joshua Schiffman M.D., M.Sc., Prof. of Pediatrics, Huntsman Cancer, U. of UtahU. of Utah	Mike Snyder's Keynote Continues	NCI Showcase David Richardson CEO, bioSyntagmabioSyntagma	AI and Data Sciences Showcase Naveen Kumar Head, BioPharma RWE, Guardant HealthGuardant Health Inc
Jan. 22 10:00 A.M.	Break, Exhibition and Networking
Jan. 22 10:30 A.M.	CAR-T Cell Therapy \| Panel Chair: Sarah Warren Ph.D., Dir. of Advanced Appl., NanoStringNanoString Tech	Data Science In Drug Discovery \| Panel Chair: Ron Alfa M.D., Ph.D., SVP, Translational Disc., Recursion PharmaRecursion Iris Grossman Ph.D., CSO, Camp4 TxCamp4 Tx	Unique Population Study Collaborations \| Panel Aleksandar Rajkovic M.D., Ph.D., Chief Genomics Officer, UCSF HealthUCSF Health Peter Hulick M.D., FACMG, Medical Dir., Ctr. for PM, NorthShore U.NorthShore U. HealthSystem	New Approaches to Clinical Trial Design and Enrollment \| Panel Chair: Steven Shak M.D., CMO, Exact SciencesExact Sciences	The Physician & Patient Perspective- Making PM Mainstream Chair: Garry Choy M.D., Founder, CMO, Q BioQ Bio	NCI Showcase Michael Henry Ph.D., Prof., The U. of Iowa, Pres., SynderBioSynderBio	AI and Data Sciences Showcase Amrie Grammer Ph.D., Co-Founder,COO, CSO, AMPEL BioSolutionsAMPEL BioSolutions
Jan. 22 10:45 A.M.	CAR-T Cell Therapy \| Panel Sean Mackay CEO & Co-Founder, IsoPlexisIsoPlexis David Miklos M.D., Ph.D., Assoc. Prof. of Medicine, Stanford U.Stanford	Data Science In Drug Discovery \| Panel Fiona Nielsen CEO & Co-Founder, RepositiveRepositive Evan N Feinberg Ph.D., CEO & Head of AI, Genesis TxGenesis Tx	Unique Population Study Collaborations \| Panel Anthony D Slonim M.D., Pres. & CEO, Renown HealthRenown Health	New Approaches to Clinical Trial Design and Enrollment \| Panel Richard Schilsky M.D., SVP & CMO, ASCOASCO	The Physician & Patient Perspective- Making PM Mainstream William P Stanford M.D., Ph.D., FACP, Founder & CMO, BHIPMBeverly Hills Inst. for PM	NCI Showcase Andrew Wang M.D., Prof., Radiation Oncology, UNC; Co-Founder, Capio Biosci.Capio Biosciences	AI and Data Sciences Showcase Atray Dixit Ph.D., CEO, Coral GenomicsCoral Genomics
Jan. 22 11:00 A.M.	CAR-T Cell Therapy \| Panel Joseph Melenhorst Ph.D., Adjunct Assoc. Prof., U. of PennsylvaniaU. of Penn	Machine Learning Enriched Antibody Discovery \| Panel Chair: Matthew P Greving Ph.D., Co-Founder & VP, RubrYc TxRubrYc Tx	Unique Population Study Collaborations \| Panel Olena Morozova Vaske Ph.D., Prof. of Molecular, Cell & Dev. Biology, UCSCUCSC	New Approaches to Clinical Trial Design and Enrollment \| Panel Fareed Melhem SVP, Acorn AI Labs, Medidata SolutionsMedidata Solutions	Health Data At Scale Keynote Chair: Jessica Mega MPH, M.D., CMO, Verily Life SciencesVerily Life Sciences	Q&A with NCI/SBIR	AI and Data Sciences Showcase Christopher Corless M.D., Ph.D., Co-Founder, CMO, Omics Data AutomationOmics Data Autom.
Jan. 22 11:15 A.M.	CAR-T Cell Therapy \| Panel Avery Posey Ph.D., Assist. Prof., U. of PennsylvaniaU. of Penn Eric Ostertag M.D., CEO, Poseida TxPoseida Tx	Machine Learning Enriched Antibody Discovery \| Panel Sridhar Govindarajan Ph.D., Cofounder, CIO, ATUMATUM Alexander Taguchi Ph.D., Machine Learning Scientist, RubrYc TxRubrYc Tx	Unique Population Study Collaborations \| Panel Jennifer Low M.D., Ph.D., Head of Tx Dev., 23andMe23andMe Clara Lajonchere Ph.D., Deputy Dir., UCLA Inst. for Prec. HealthUCLA	New Approaches to Clinical Trial Design and Enrollment \| Panel Mika Newton CEO, xCuresxCures	Jessica Mega's Continues	Genomic Profiling Showcase Maggie Rougier-Chapman VP of Global Marketing, Bionano GenomicsBionano Genomics	AI and Data Sciences Showcase Daphna Laifenfeld Ph.D., CSO, Ibex Medical AnalyticsIbex Medical Analytics
Jan. 22 11:30 A.M.	CAR-T Value Evidence Melanie D Whittington Ph.D., MS, Assist. Research Prof., U. of ColoradoU. of Colorado	Fireside Chat 3 - AI/ML Data Sciences Chair: Lars Steinmetz Ph.D., Co-Founder, SOPHiA GENETICSSOPHiA GENETICS	Microbial DNA: Beyond Infectious Diseases \| Panel Chair: Sandrine Miller-Montgomery Ph.D., Exec. Dir., Ctr. for Microbiome Innov., UCSDUCSD	Advances And Future Perspectives In Single Cell Analysis \| Panel Chair: Allison Ballmer B.S., VP, Agilent TechAgilent Tech	Automated Patient Detection for Trials Anil Sethi Founder, CiitizenCiitizen	Genomic Profiling Showcase Hans Cobben CEO, BlueBeeBlueBee	AI and Data Sciences Showcase Avi Veidman CEO, NucleaiNucleai
Jan. 22 11:45 A.M.	Cancer Neoantigen Vaccines Chair: Andrew Allen M.D., Ph.D., Pres. & CEO, Gritstone OncologyGritstone Oncology	Fireside Chat 3 - AI/ML Data Sciences Phil Febbo M.D., CMO, lluminaIllumina	Microbial DNA: Beyond Infectious Diseases \| Panel Robert Jenq M.D., Prof., Genomic Medicine & Dir. Microbiome Core, MD AndersonMD Anderson Mickey Kertesz Ph.D., CEO, KariusKarius Kate Markey MBBS, Ph.D., Physician at Memorial Sloan Kettering Cancer Ctr.Memorial Sloan Kettering	Advances And Future Perspectives In Single Cell Analysis \| Panel Peter Smibert Ph.D., Senior Manager, Tech. Innovation Lab, NY GenomeNY Genome Ctr. Charlie Silver Ph.D., CEO, Mission BioMission Bio Hanlee Ji M.D., Prof. & Senior Assoc. Dir., Division of Oncology, StanfordStanford	California State Government's Efforts in Precision Medicine Shannon Muir Ph.D., Science Officer, Governor’s Off. of Planning & Res.Governor Office of Planning & Research	Genomic Profiling Showcase I-Jane Chen Ph.D., Microfluidic Devices Manager, Complete GenomicsComplete Genomics	AI and Data Sciences Showcase Nabil Hafez Senior Dir., Product Management, BD & Marketing, SunquestSunquest Information Systems
Jan. 22 12:00 P.M.	Break, Exhibition and Networking
Jan. 22 1:00 P.M.	Clinical Applications of Microbiome in Cancer Chair: Marcel van den Brink M.D., Ph.D., Head, Div. Hematologic Malignancies, MSKCCMemorial Sloan Kettering	AI/ML-Driven Clinical Trial Design and Patient Selection \| Panel Chair: Shweta Singh Maniar Strategic Global Client Lead, Google CloudGoogle Cloud	Preventing Global Disparities in Genomic Healthcare \| Panel Chair: Nadeem Sarwar M.D., Ph.D., Pres., G2D2, EisaiEisai	NGS Workflows For Clinical Diagnostics Applications \| Panel Chair: Noam Shomron Ph.D., Head, Genomics Intelligence, Tel Aviv U.Tel Aviv U.	Making Precision Medicine Mainstream With Health Data: Challenges To Acceleration \| Panel Chair: Marylyn D Ritchie Ph.D., Dir., Ctr. for Transl. Bioinformatics, U. of PennU. of Penn	Genomic Profiling Showcase William Audeh M.D., CMO, AgendiaAgendia	AI and Data Sciences Showcase Rafael Rosengarten Ph.D., CEO, GenialisGenialis
Jan. 22 1:15 P.M.	Clinical Applications of Microbiome in Cancer Joe Ponte Ph.D., Senior Dir. Host Biology, Seres TxSeres Tx	AI/ML-Driven Clinical Trial Design and Patient Selection \| Panel Marc Fiume Ph.D., Co-Founder & CEO, DNAstackDNAstack Mohammed Ali Global Head, Digital Dev., Global Clinical Op., Boehringer IngelheimBoehringer Ingelheim	Preventing Global Disparities in Genomic Healthcare \| Panel Peter Goodhand CEO, Global Alliance for Genomics & HealthGlobal Alliance for Genomics & Health Amer Haider EntrepreneurEntrepreneur Matthew Nelson Ph.D., VP, Genetics & Genomics, DeerfieldDeerfield Alicia Martin Ph.D., Instructor of Investigation, Massachusetts General Hospital & Broad Inst.Broad Inst.	NGS Workflows For Clinical Diagnostics Applications \| Panel Luca Quagliata Ph.D., Global Head of Medical Affairs, Thermo FisherThermo Fisher Hans Cobben CEO, BlueBeeBlueBee	Making Precision Medicine Mainstream With Health Data: Challenges To Acceleration \| Panel Dana Crawford Ph.D., Assoc. Prof., Case Western Reserve U.Case Western Reserve U.	Genomic Profiling Showcase David Spetzler Ph.D., Pres. & CSO, Caris Life SciencesCaris	AI and Data Sciences Showcase Francisco Diaz-Mitoma CEO, Bowhead HealthBowhead Health
Jan. 22 1:30 P.M.	Tumor Microenvironment \| Panel Chair: Samantha Bucktrout Ph.D., Dir. of Research, Parker Inst.Parker Inst. Michael Angelo M.D., Ph.D., Assist. Prof. of Pathology, StanfordStanford	AI/ML-Driven Clinical Trial Design and Patient Selection \| Panel Emma Shtivelman Ph.D., Chief Scientist, Cancer CommonsCancer Commons	Implementing Precision Medicine in Community Hospitals \| Panel Chair: Michael Pellini M.D., M.B.A, Managing Partner, Section 32Section 32 Costanzo Di Perna VP Oncology Service Line GSSA, Dignity HealthDignity Health	NGS Workflows For Clinical Diagnostics Applications \| Panel David Haussler Ph.D., Scientific Dir., UC Santa Cruz Genomics Inst.UCSC	Making Precision Medicine Mainstream With Health Data: Challenges To Acceleration \| Panel Jennifer K Wagner J.D., Ph.D., Prof., Ctr. for Translational Bioethics & Healthcare Policy, GeisingerGeisinger	Genomic Profiling Showcase Marcin Piechota Ph.D., VP & Chief Technology Officer, IntelliseqIntelliseq	AI and Data Sciences Showcase Brian D Athey Ph.D., CSO & CTO, Phenomics HealthPhenomics Health Inc
Jan. 22 1:45 P.M.	Tumor Microenvironment \| Panel Travis Hollmann M.D.,Ph.D., Dermatopathologist, MSKCCMemorial Sloan Kettering Henry Hepburne-Scott President, Co-founder of SerametrixCaprion Biosciences	AI/ML-Driven Clinical Trial Design and Patient Selection \| Panel Armin Schneider M.D., Ph.D., VP Sci. & Med. Affairs, Molecular HealthMolecular Health	Implementing Precision Medicine in Community Hospitals \| Panel Adrian V Lee Ph.D., Prof. & Dir., Inst. for PM, U. of PittsburghU. of Pittsburgh Terry Wooten VP of Operations, Support Services, St. Joseph HealthSt Joseph Health	NGS Workflows For Clinical Diagnostics Applications \| Panel Mark Van Oene Chief Commercial Officer, IlluminaIllumina Lou Welebob VP, Commercial Marketing, Agilent TechAgilent Tech	Q&A	Genomic Profiling Showcase Victoria Reid Dir., Market Dev., 10x Genomics10x Genomics	AI and Data Sciences Showcase Mark Mooney Ph.D., Customer Success, Tag.bioTagbio
Jan. 22 2:00 P.M.	Immunotherapy IP James J Mullen III Ph.D., Patent Partner, Morrison & FoersterMorrison & Foerster	Data Mining and Visualization \| Panel Chair: David Shaywitz M.D., Ph.D., Founder, Astounding HealthTechAstounding HealthTech	Creating A Sustainable Genomic Testing Service Within Healthcare Systems That Improves Outcomes \| Panel Chair: Phil Febbo M.D., CMO, lluminaIllumina	Experiences And Perspectives On Clinical Decision Support At The Point Of Care \| Panel Chair: Chris Cournoyer Board of Directors, CareDx, Strategic Advisor, QIAGENQIAGEN Digital Insights	Moving Genomics To Standard of Care: Scalable Return Of Results \| Panel Chair: Justin Kao Co-founder & SVP, BD & Strategy, HelixHelix	Genomic Profiling Showcase Radhakrishna Bettadapura Head of BD, Strand Life SciencesStrand Life Sciences	AI and Data Sciences Showcase Shannon Kieran MS, LCGC, MBA, Executive VP, GenomeSmartGenomeSmart
Jan. 22 2:15 P.M.	Speeding Investigational Cancer Drugs for Patients \| Panel Chair: Theresa LaVallee Ph.D., VP, Translational Medicine & Regulatory Affairs, Parker Inst.Parker Inst.	Data Mining and Visualization \| Panel Aalpen Patel M.D., FSIR, Chairman, Dept. of Radiology, GeisingerGeisinger Kaisa Helminen M.Sc., CEO, Aiforia TechAiforia Tech	Creating A Sustainable Genomic Testing Service Within Healthcare Systems That Improves Outcomes \| Panel Lee Newcomer M.D., Principal, Lee N Newcomer ConsultingLee N Newcomer Consulting	Experiences And Perspectives On Clinical Decision Support At The Point Of Care \| Panel Kenna R Mills-Shaw Ph.D., Executive Dir., MD AndersonMD Anderson	Moving Genomics To Standard of Care: Scalable Return Of Results \| Panel Huntington F Willard Ph.D., Dir., Geisinger National Precision Health; Assoc. CSO, Prof., GeisingerGeisinger	Genomic Profiling Showcase Richard Chen M.D., MS, CSO, PersonalisPersonalis	AI and Data Sciences Showcase Carla Grandori M.D., Ph.D., CEO, SEngine PMSEngine PM
Jan. 22 2:30 P.M.	Speeding Investigational Cancer Drugs for Patients \| Panel Richard Schilsky M.D., SVP & CMO, ASCOASCO	Data Mining and Visualization \| Panel Martin Stumpe Ph.D., SVP, Head of Data Science, Tempus LabsTempus Sean Khozin M.D., Global Head of Data Strategy, Janssen R&D/J&JJanssen Pharma	Creating A Sustainable Genomic Testing Service Within Healthcare Systems That Improves Outcomes \| Panel Anthony R Gregg M.D., Chief, Dept. of Obstetrics & Gynecology & Maternal-Fetal Medicine, Baylor U.Baylor U. Medical Ctr.	Experiences And Perspectives On Clinical Decision Support At The Point Of Care \| Panel Robert Hauser Ph.D., Chief BD & Analytics Officer, CTCACTCA	Moving Genomics To Standard of Care: Scalable Return Of Results \| Panel Teresa Kruisselbrink Genetic Counselor, Supervisor, Ctr. for Individ. Med., Mayo ClinicMayo Clinic	Clinical Dx Showcase Ronnie Andrews CEO, OncoCyteOncoCyte	AI and Data Sciences Showcase Mylene Yao M.D., CEO & Co-Founder, UnivfyUnivfy Inc
Jan. 22 2:45 P.M.	Speeding Investigational Cancer Drugs for Patients \| Panel Ramy Ibrahim M.D., CMO & VP, Clinical Dev., Parker Inst.Parker Inst.	How Epic Solutions Reduce Errors, Improve Patient Safety and Support Better Patient Outcomes Russ Cucina M.D., Prof. of Medicine, UCSFUCSF	Q&A	Experiences And Perspectives On Clinical Decision Support At The Point Of Care \| Panel Anna Berry M.D., Dir. for Molecular Pathology & Genomics, Swedish CancerSwedish Cancer	Moving Genomics To Standard of Care: Scalable Return Of Results \| Panel Cassie Hajek M.D., Chair & Medical Dir., Sanford ImageneticsSanford Imagenetics	Clinical Dx Showcase Clifford A Reid Ph.D., CEO, TraveraTravera	AI and Data Sciences Showcase Einat Metzer CEO & Co-Founder, EmedgeneEmedgene
Jan. 22 3:00 P.M.	Break, Exhibition and Networking
Jan. 22 3:30 P.M.	Improving Response To Checkpoint Blockade Therapies \| Panel Chair: Danny Wells Ph.D., Data Scientist, Parker Inst.Parker Inst.	FDA Perspective – Strategies For Modernizing Clinical Development \| Panel Chair: Stanley Huff M.D., CMIO, Intermountain HealthcareIntermountain	Precision Oncology In Practice For The Earliest Stages Of Cancer When It Is Most Treatable \| Panel Chair: Ronnie Andrews CEO, OncoCyteOncoCyte	Uncovering Data through Cancer Genomic Profiling \| Panel Chair: Ellen Matloff CEO, My Gene CounselMy Gene Counsel	Workplace Genomics: How Employers Are Adopting Genetics And Genomics For Their Members \| Panel Chair: Lisa Alderson M.B.A, Co-founder & CEO, Genome MedicalGenome Medical	Clinical Dx Showcase Tim Sweeney Ph.D., CEO, InflammatixInflammatix	AI and Data Sciences Showcase Xiang Sean Yao Ph.D., Principal & Comp. Scientist, Janssen Pharma of J&JJanssen Pharma
Jan. 22 3:45 P.M.	Improving Response To Checkpoint Blockade Therapies \| Panel Hussein Tawbi M.D., Ph.D., Dir. Melanoma Clinical Res., U. of TexasMD Anderson	FDA Perspective – Strategies For Modernizing Clinical Development \| Panel Michael Waters Ph.D., SHIELD Team Lead & IVD RWE Representative, FDAFDA	Precision Oncology In Practice For The Earliest Stages Of Cancer When It Is Most Treatable \| Panel David Jablons M.D., Prof. & Chief, Div. General Thoracic Surgery, Prof. & Program Leader, Thoracic Oncology, UCSFUCSF Bonnie Addario Co-Founder & Board Chair, GO2 Foundation for Lung CancerGO2 Foundation for Lung Cancer David Gandara M.D., Prof., UC Davis Comprehensive Cancer Ctr.UC Davis Compre. Cancer Ctr.	Uncovering Data through Cancer Genomic Profiling \| Panel Suzanne Belinson Ph.D., MPH, VP Commercial Markets, TempusTempus Rebecca J Nagy MS LGC, Senior Dir., Medical Affairs US, Guardant HealthGuardant Health Inc	Workplace Genomics: How Employers Are Adopting Genetics And Genomics For Their Members \| Panel Pat Leckman VP, Human Resources, IlluminaIllumina	Clinical Dx Showcase Elisa Romeo Ph.D., COO, Drawbridge HealthDrawbridge Health Inc	AI and Data Sciences Showcase Arash Keshavarzi Arshadi Research Fellow, Ph.D. Student, U. of Central FloridaU. of Central Florida
Jan. 22 4:00 P.M.	Improving Response To Checkpoint Blockade Therapies \| Panel Robert M Prins Ph.D., Prof.,Molecular & Med. Pharma., UCLAUCLA	FDA Perspective – Strategies For Modernizing Clinical Development \| Panel James Tcheng M.D., Prof. of Medicine, Prof. of Informatics, DukeDuke U.	The Participant At The Center \| Panel Chair: Premal Shah Ph.D., Pres. & Co-Founder, CiitizenCiitizen	Uncovering Data through Cancer Genomic Profiling \| Panel Cindy Perettie CEO, Foundation MedicineFoundation Medicine	Workplace Genomics: How Employers Are Adopting Genetics And Genomics For Their Members \| Panel Annette Falkowski Benefits Programs Manager, Exact SciencesExact Sciences	Clinical Dx Showcase Andrew Garazha CEO, OncoboxOncobox	AI and Data Sciences Showcase Vasu Rangadass Ph.D., CEO, L7 InformaticsL7 Informatics Inc
Jan. 22 4:15 P.M.	Improving Response To Checkpoint Blockade Therapies \| Panel Elizabeth Mittendorf M.D.,Ph.D., Dir., Breast IO Program, Dana-FarberDana Farber Cancer Inst. Elizabeth Burton MBA, Dir., Research Planning, & Dev. Melanoma, MD AndersonMD Anderson	VC Perspective And Fund-Raising Strategies \| Panel Chair: Greg Yap MBA, Partner, Menlo VenturesMenlo Ventures	The Participant At The Center \| Panel Dawn Barry M.B.A., Pres. & Co-founder, LunaDNALunaDNA Sharon Terry Co-founder, Pres. & CEO Genetic Alliance Registry & Biobank & PXEGenetic Alliance Heidi Bjornson-Pennell Patient Engagement Strategist, Chan Zuckerberg InitiativeChan Zuckerberg Initiative	Uncovering Data through Cancer Genomic Profiling \| Panel Shari Brown M.D., Dir. of Molecular Pathology Services, NeoGenomicsNeoGenomics Laboratories	Workplace Genomics: How Employers Are Adopting Genetics And Genomics For Their Members \| Panel Robert Goldsmith M.D., Exec. Dir., Corp. Employee Health, Novartis ServicesNovartis Services Inc Jeffrey Davis M.D., Corporate Medical Director, CiscoCisco	Clinical Dx Showcase Chris MacDonald Ph.D., VP, Operations & Data Science, ChromaCodeChromaCode Inc	AI and Data Sciences Showcase Manisha Shetty Gulati COO, Clarify Health SolutionsClarify Health Solns.
Jan. 22 4:30 P.M.	Building A Cancer Immunotherapy Data Science Platform Lacey Kitch Ph.D., Dir., Informatics, Parker Inst.Parker Inst.	VC Perspective And Fund-Raising Strategies \| Panel Nan Li Managing Dir., Obvious VenturesObvious Ventures Vineeta Agarwala M.D., Ph.D., General Partner, Andreessen HorowitzAndreessen Horowitz	The Participant At The Center \| Panel Bray Patrick-Lake Dir., Strategic Partnership, Evidation HealthEvidation Health	FDA Guidelines for RWE Michael Waters Ph.D., SHIELD Team Lead & IVD RWE Representative, FDAFDA	Cheating Premature Death: Quantitative Genetic, Imaging And Blood Biomarkers David S Karow M.D., Ph.D., Chief of Radiogenomics & Interim CEO, Human LongevityHuman Longevity	Clinical Dx Showcase Raj Krishnan Ph.D., CEO, Biological Dynamics, IncBiological Dynamics Inc	AI and Data Sciences Showcase Hiren Shah Founder & CEO, HumaniticsHumanitics
Jan. 22 4:45 P.M.	VC Perspectives on Immunotherapy Investing \| Panel Chair: Risa Stack Ph.D., Managing Dir., RS BioventuresRS Bioventures Jorge Conde General Partner, Andreessen HorowitzAndreessen Horowitz	Semantic AI In Drug Discovery And Clinical Trials \| Panel Chair: Janusz Dutkowski Ph.D., Co-founder & CEO, Data4CureData4Cure	Engaging Participants as Partners to Advance Precision Medicine Chair: Camille Nebeker Ed.D., M.S., Assoc. Prof., UC San DiegoUCSD	Enabling Effective Transition From Clinical Research To Cancer Care Sharanya Raghunath Ph.D., Dir. of Bioinformatics, Intermountain HealthcareIntermountain	A Decade Long Journey Of ID DX Kfir Oved Ph.D., Co-Founder & CTO, MeMed DiagnosticsMeMed Diagnostics	Clinical Dx Showcase Noam Shomron Ph.D., Prof., Head, Genomics Intelligence, Tel Aviv U.Variantyx	AI and Data Sciences Showcase Ingrid Vasiliu Feltes M.D., Chief Quality & Innovation Officer, MEDNAXMEDNAX
Jan. 22 5:00 P.M.	VC Perspectives on Immunotherapy Investing \| Panel Nina Kjellson General Partner, CanaanCanaan Brian Daniels M.D., Partner, 5AM Ventures5AM Ventures	Semantic AI In Drug Discovery And Clinical Trials \| Panel Pallavi Sachdev MPH, Ph.D., Dir., Oncology Biomarker Research, EisaiEisai Inc Paul Rejto Ph.D., VP, Oncology Translational Research, PfizerPfizer	Unlocking The Potential Of Precision Medicine In Primary Care Chair: Mylynda B Massart M.D., Ph.D., Assist. Prof., UPMCU. of Pittsburgh		Metagenomic Testing for Infectious Disease Hannah Sample Program Manager, UCSFUCSF
Jan. 22 5:30 P.M.	Closing

January 23

	Track 1	Track 2	Track 3	Track 4	Track 5	Track 6	Track 7
January 23
Jan. 23 8:00 A.M.	Registration and Networking
Jan. 23 9:00 A.M.	Immunotherapy Track continues Translating The Brilliance Of The Adaptive Immune System Lance Baldo M.D., CMO, Adaptive BiotechAdaptive Biotech	Driving Toward Value-Based Care \| Panel Stanley Huff M.D., CMIO, Intermountain HealthcareIntermountain	Women’s Health Chair: Aleksandar Rajkovic M.D., Ph.D., Chief Genomics Officer, UCSFUCSF Health	Path to Coverage: Understanding and AV, CV, and CU Gabriel A Bien-Willner M.D., Ph.D., Medical Dir., MolDX; CMO, Palmetto GBAPalmetto	Microbiome Based Precision Medicine: State Of The Science \| Panel Chair: Karim Dabbagh Ph.D., Pres. & CEO, Second GenomeSecond Genome	Immunotherapy Showcase Lee Rafsky Ph.D., Medical Science Liaison, Jounce TxJounce Tx	Liquid Biopsy Showcase Jesse Salk M.D., Ph.D., CEO, Twinstrand BiosciencesTwinstrand Biosciences
Jan. 23 9:15 A.M.	Immunotherapy Track continues A 1st-in-Human CAR-T for Solid Tumors That Targets A Cleaved MUC1 Cynthia Bamdad Ph.D., CEO, Minerva BiotechMinerva Biotech	Driving Toward Value-Based Care \| Panel Matt Obenhaus Dir., Cerner Open Developer Experience, CernerCerner Open Dev. Exp. Jeffrey Danford Senior Principal Software Engineer, AllscriptsAllscripts	Reproductive Women's Health Overview Michelle Strecker Medical Affairs Liaison, InvitaeInvitae	Investing In Lab Services And Technologies \| Panel Chair: Thomas Hawes M.D., Managing Dir., BCBSVPBlueCross BlueShield Venture Partners	Microbiome Based Precision Medicine: State Of The Science \| Panel Scott Plevy M.D., CSO, Synlogic TxSynlogic Tx Ethan Grant Ph.D., Dir., Biomarker Sciences, Gilead SciencesGilead Sciences Dave Ousterout Ph.D., CSO & Co-Founder, Locus BiosciencesLocus Biosciences	Immunotherapy Showcase James Lim Ph.D., CSO, Xcell BiosciencesXcell Biosciences	Liquid Biopsy Showcase Bahram G Kermani Ph.D., CEO, Crystal GeneticsCrystal Genetics Inc
Jan. 23 9:30 A.M.	CVD Track -The Genetics Of Heart Disease Chair: Calum MacRae M.D.,Ph.D., Vice Chair, Scientific Innovation, HarvardHarvard	Driving Toward Value-Based Care \| Panel Janet Campbell VP, R&D Relations, EpicEpic	Preterm Birth & The Promise Of Biomarkers Amy Murtha M.D., Prof. & Chair, Obstetrics, Gynecology, UCSFUCSF	Investing In Lab Services And Technologies \| Panel Dave J Daly CEO, Thrive Earlier DetectionThrive Earlier Detection Kevin Hrusovsky M.B.A, Pres., Chair. & CEO, Quanterix; Founder & Chair., Powering Precision HealthQuanterix	Fecal Microbiota Transplantation Tor Savidge Ph.D., Prof., Dept. of Pathology & Immunology, BaylorBaylor College of Medicine	Immunotherapy Showcase Pirouz Daftarian Ph.D., Senior Manager, Immunoncology & Vaccines, JSRJSR Life Sciences	Liquid Biopsy Showcase Nicholas Dracopoli Ph.D., CSO, Delfi DiagnosticsDelfi Diagnostics
Jan. 23 9:45 A.M.	CVD Track -The Genetics Of Heart Disease Keynote continues	Healthcare on FHIR: Innovation in Data Exchange & Analytics Charles Jaffe M.D., Ph.D., CEO, HL7HL7	Preterm Birth & The Promise Of Biomarkers Laura Jelliffe-Pawlowski Ph.D., Assoc. Prof., Epidemiology & Biostatistics & Dir. of Discovery & Precision Health, UCSF CA Preterm Birth Initiative, UCSF School of MedicineUCSF	Investing In Lab Services And Technologies \| Panel William Hagstrom CEO, Founder, Octave BioSciencesOctave BioSciences	Microbiome Profiling through “Omics” Methods Sandrine Miller-Montgomery Ph.D., Exec. Dir., Ctr. for Microbiome Innov., UCSDUCSD	Immunotherapy Showcase CP Liu Ph.D., Executive Chair, Angarus TxAngarus Tx	Liquid Biopsy Showcase Sam Salman Chairman & CEO, ImpactNRS & Chairman, CEO, miR ScientificmiR Scientific
Jan. 23 10:00 A.M.	Break, Exhibition and Networking
Jan. 23 10:30 A.M.	Deriving Cardiovascular Clinical Insight from Remote Sensors \| Panel Chair: Geoff Tison M.D., M.P.H., Cardiologist; & Prof., UCSF HealthUCSF Health	Data Science Drives Healthcare Chair: Andrew Kasarskis Ph.D., CDO & Executive VP, Mount Sinai Health SystemMount Sinai Health System	Preterm Birth & The Promise Of Biomarkers Stephen Quake Ph.D., Lee Otterson Prof. of Engineering, StanfordStanford	Clinical Biomarker Discovery, Validation Timothy Looney Ph.D., Staff Scientist, Bioinformatics, Thermo FisherThermo Fisher	Fireside Chat: Microbe-specific Therapies Keith Yamamoto Ph.D., Vice Chancellor for Science Policy & Strategy, UCSF; Dir., UCSF PM, UCSFUCSF	Immunotherapy Showcase Omar Duramad Ph.D., CSO, BryoLogyxBryoLogyx	Liquid Biopsy Showcase continues Ted Snelgrove Chief Business Officer, Lexent BioLexent Bio
Jan. 23 10:45 A.M.	Deriving Cardiovascular Clinical Insight from Remote Sensors \| Panel Gregory M Marcus M.D., M.A.S., Assoc. Chief of Cardiology for Research, UCSF HealthUCSF Health Liviu Klein M.D., Dir., Mechanical Circulatory Support & Heart Failure Device Programs, UCSFUCSF	Data Science Drives Healthcare Christopher P Boone Ph.D., VP, Global Med. Epidemiology & Big Data Analysis, PfizerPfizer	Non Invasive Prenatal Testing (NIPT) Brynn Levy Ph.D., Prof. of Pathology & Cell Biology, ColumbiaColumbia U. Medical Ctr.	Regulatory & Reimbursement Risk/Reward In Clinical CDx \| Panel Chair: Hannah Murphy Executive Dir., Coalition for 21st Century MedicineCoalition for 21st Century Medicine	Fireside Chat: Microbe-specific Therapies Margaret Peg Riley Ph.D., Prof., Dept. of Biology, UMass AmherstU. of Massachusetts Amherst	Immunotherapy Showcase Ray Takigiku Ph.D., CEO, Bexion PharmaBexion Pharma	Liquid Biopsy Showcase James Berenson M.D., Pres. & CSO, OncoTrackerOncoTracker Inc
Jan. 23 11:00 A.M.	Navigating the Challenges of Reimbursement \| Panel Chair: John J Sninsky Ph.D., Consultant, Translational SciencesTranslational Consultant	Data Science Drives Healthcare Jonathan Carlson Ph.D., Dir. of Immunomics, MicrosoftMicrosoft	The Evolution Of Genetic Carrier Screening Jennifer Saucier Dir., Genetic Counseling Services, NateraNatera	Regulatory & Reimbursement Risk/Reward In Clinical CDx \| Panel Sheila D Walcoff J.D., CEO & Founder, Goldbug StrategiesGoldbug Strategies	Microbiome Profiling through “Omics” Methods Chair: Manoj Dadlani CEO, CosmosIDCosmosID	Immunotherapy Showcase Vicki Plaks Ph.D., Principal Scientist, Kite, A Gilead CompanyKite a Gilead	Liquid Biopsy Showcase David Ge Ph.D., CEO, ApostleApostle
Jan. 23 11:15 A.M.	Navigating the Challenges of Reimbursement \| Panel Bruce Quinn M.D., Ph.D., Principal, Bruce Quinn Assoc.Bruce Quinn Assoc.s Susan Xu Dir., Payment Policy Research & Analytics, AAMCAssociation of American Medical Colleges	Data Science Drives Healthcare Sharat Israni Ph.D., Executive Dir. & CTO, Bakar Inst., UCSFUCSF Sharmila Majumdar Ph.D., Vice Chair of Research, Radiology, UCSFUCSF	Infertility Outcomes: Genetics And Epigenetics Margareta D Pisarska M.D., Dir., Ctr. for Fertility & Reproductive Med., Cedars-SinaiCedars Sinai	Regulatory & Reimbursement Risk/Reward In Clinical CDx \| Panel Pamela Bradley Ph.D., Dir. of Policy & Advocacy, Adaptive BiotechAdaptive Biotech Tina Hambuch Ph.D., Clinical Laboratory Dir., InvitaeInvitae	Microbiome Profiling through “Omics” Methods Morten Isaksen Ph.D., CEO, Bio-MeBio Me	AI and Data Sciences Showcase Todd Oakland Ph.D., Principal, GNS HealthcareGNS Healthcare	Liquid Biopsy Showcase Thomas Briggs Sr. Key Account & Business Dev. Manager, BDPreAnalytiX
Jan. 23 11:30 A.M.	Navigating the Challenges of Reimbursement \| Panel Steve Anderson Ph.D., CSO, Covance, Sr VP, LabCorpLabCorp	Data Science Drives Healthcare Wendy Nilsen Ph.D., Program Dir., National Science FoundationNSF	AI in IVF: Selection Of Optimal Embryo Nikica Zaninovic Ph.D., Assoc. Prof., Lab Dir., Weill Cornell MedicineWeill Cornell Medicine	The Promise & Price of RWE: The Rapid Time to Market Balanced with Patient Care \| Panel Chair: Trevor Page Chief Business Officer, Companion Diagnostics, Agilent TechAgilent Tech Lou Welebob VP, Commercial Marketing, Agilent TechAgilent Tech	Microbiome Profiling through “Omics” Methods Martha Carlin CEO & Founder, The BioCollectiveThe BioCollective	AI and Data Sciences Showcase Blanca Baez MBA, SVP, Global Head Pharma & Biotech, Molecular HealthMolecular Health	Liquid Biopsy Showcase Taylor Jensen Ph.D., Dir., R&D, Integrated Oncology, LabCorpLabCorp
Jan. 23 11:45 A.M.	Navigating the Challenges of Reimbursement \| Panel Gabriel A Bien-Willner M.D., Ph.D., Medical Dir., MolDX; CMO, Palmetto GBAPalmetto	Data Science Drives Healthcare Sonoo Thadaney Israni Executive Dir., Presence & Program in Bedside Med., StanfordStanford	Expanded Carrier Screening For Serious Inherited Disorders James Goldberg M.D., CMO, Myriad Women’s HealthMyriad Womens Health	The Promise & Price of RWE: The Rapid Time to Market Balanced with Patient Care \| Panel Scott Patterson Ph.D., VP, Biomaker Sciences, Gilead SciencesGilead Sciences Mirella Lazarov Ph.D., Head, Companion Diagnostics Ctr. of Excellence, AbbVieAbbVie	Microbiome Profiling through “Omics” Methods Aaron Del Duca VP, Microbiome Platform, DayTwoDayTwo	AI and Data Sciences Showcase Roy Malka Ph.D., VP Data Sciences, K HealthK Health	Liquid Biopsy Showcase Anna Bergamaschi Ph.D., Principle Scientist, Bluestar GenomicsBluestar Genomics
Jan. 23 12:00 P.M.	Break, Exhibition and Networking
Jan. 23 1:00 P.M.	Emerging Risk-Associated Biomarkers Chair: Siddhartha Jaiswal M.D., Ph.D., Assist. Prof., Stanford U.Stanford	Data Science In Hospitals & Health Systems Chair: Somalee Datta Ph.D., Dir., Research IT, Stanford MedicineStanford Medicine	Preterm Birth and Oral Health Michael Reddy Dean & Prof., UCSFUCSF School of Dentistry	Leveraging RWE To Drive Decisions \| Panel Chair: Jonathan Sheldon Ph.D., SVP, Bioinformatics Business Area, QIAGENQIAGEN Digital Insights	Microbiome Profiling through “Omics” Methods Brian Keppler Ph.D., Scientific Dir., MetabolonMetabolon Inc	Wellness and Aging Showcase Pamila Brar M.D., CMO, JCVIJ Craig Venter Inst.	Liquid Biopsy Showcase Lauren Leiman Executive Dir., BloodPACBloodPAC
Jan. 23 1:15 P.M.	Emerging Cardiomyopathy Therapeutics Chair: Marc Semigran M.D., SVP, Medical Sciences, MyoKardiaMyoKardia	Data Science In Hospitals & Health Systems Amy PK Nelson Senior Research Assoc., Inst. of Neurology, UCLUCL	In Vitro Fertilization Akash Kumar M.D., Ph.D., Co-Founder, MyOmeMyOme Inc	Leveraging RWE To Drive Decisions \| Panel Laura J van't Veer Ph.D., Inventor, MammaPrint; Dir. Applied Genomics, UCSFUCSF	Microbiome Profiling through “Omics” Methods Sanjay Joshi Industry CTO Healthcare, Dell EMCDell EMC	Wellness and Aging Showcase Peter Fedichev Ph.D., CEO, Gero.AIGeroAI	Clinical Dx Showcase John Simmons Ph.D., VP, Translational Medicine, PGDxPGDx
Jan. 23 1:30 P.M.	Cardiovascular Imaging Campbell Rogers M.D., Executive VP & CMO, HeartFlowHeartFlow	Data Science In Hospitals & Health Systems Parsa Mirhaji M.D., Ph.D., Dir., Montefiore Health SystemMontefiore Health System	In Vitro Fertilization Claire Tomkins Ph.D., Founder, CEO, Future FamilyFuture Family	Leveraging RWE To Drive Decisions \| Panel Christopher P Boone Ph.D., VP, Global Med. Epidemiology & Big Data Analysis, PfizerPfizer	Microbiome Profiling through “Omics” Methods Dan Knights Ph.D., Assoc. Prof., U. of Minnesota; CEO, CoreBiomeCoreBiome	Wellness and Aging Showcase Erin Trimble Head of Health Partnerships, 23andMe23andMe	Clinical Dx Showcase Tom Schoenherr Chief Commercial Officer, Ambry GeneticsAmbry Genetics
Jan. 23 1:45 P.M.	Cardiovascular Imaging for a Precision Medicine Future \| Panel Chair: Rima Arnaout M.D., Assist. Prof. of Medicine, UCSFUCSF	Implementing ML-Based Decision Support in Hospitals & Healthcare Systems \| Panel Chair: Michael Hogarth M.D., Prof., Biomedical Informatics & CRIO, UCSDUCSD	Menopause and Early Predictors Marcelle Cedars M.D., Dir., Ctr. for Reproductive Health, UCSFUCSF	Leveraging RWE To Drive Decisions \| Panel David Freeman General Manager, Information Ventures, Quest DiagnosticsQuest Diagnostics	Skin Microbiome Larry Weiss M.D., CEO & Founder, Persona BiomePersona Biome	Health Monitoring Showcase Elias Arjan VP of Strategic Dev., BiostrapBiostrap	Clinical Dx Showcase John J Sninsky Ph.D., Consulting CSO, Molecular StethoscopeMolecular Stethoscope
Jan. 23 2:00 P.M.	Cardiovascular Imaging for a Precision Medicine Future \| Panel Mona Flores M.D., MBA, Global Lead, Hospitals & Academic Medical Ctr, NVIDIANVIDIA	Implementing ML-Based Decision Support in Hospitals & Healthcare Systems \| Panel John Mattison M.D., Emeritus CMIO & Asst. Med Dir. KaiserKaiser	Breast Cancer Genetics: Molecular Tumor Signatures and Hereditary Cancer Tests \| Panel Chair: Ramesh Hariharan Ph.D., GM, Reproductive Health, NateraNatera	Patient-Specific Cancer Monitoring With Droplet Digital PCR Chair: George Karlin-Neumann Ph.D., Dir. Sci. Affairs, Digital Biology Ctr., Bio-RadBio Rad Laboratories	Skin Microbiome Mark S Wilson Co-founder & CEO, MatriSys BioscienceMatriSys Bioscience	Emerging Therapeutics Showcase Anna Moore Ph.D., Dir., Prec. Health Program, Assist. Dean, College of Human Med., Michigan StateMichigan State U.	Clinical Dx Showcase Robert Woodward Ph.D., Senior Vice-Pres. Research & Dev., CareDxCareDx
Jan. 23 2:15 P.M.	Cardiovascular Imaging for a Precision Medicine Future \| Panel Bimba Rao Ph.D., Dir. of Engineering, AI Group, Siemens HealthineersSiemens Healthineers Michael D Lesh SM, M.D., FACC, Exec. Dir., Health Tech Innovation, UCSFUCSF	Implementing ML-Based Decision Support in Hospitals & Healthcare Systems \| Panel Albert Marinez Chief Analytics Officer, Intermountain HealthcareIntermountain	Breast Cancer Genetics: Molecular Tumor Signatures and Hereditary Cancer Tests \| Panel George Sledge JR., M.D., Prof., Division Chief, StanfordStanford	Patient-Specific Cancer Monitoring With Droplet Digital PCR Isaac Garcia-Murillas Ph.D., Staff Scientist, Breast Cancer Now Ctr., ICRInst. of Cancer Research UK	Microbiome And Metabolic Disorders Colleen Cutcliffe Ph.D., CEO, Pendulum TxPendulum Tx	Emerging Therapeutics Showcase Jason Steiner Ph.D., VP, Business Dev., SynthegoSynthego	Clinical Dx Showcase Wei Zhang Ph.D., Dir., Ctr. for Cancer Genomics, Wake ForestWake Forest Health
Jan. 23 2:30 P.M.	Cardiovascular Imaging for a Precision Medicine Future \| Panel Maulik Majmudar M.D., Medical Officer, Devices & Services, AmazonAmazon	Implementing ML-Based Decision Support in Hospitals & Healthcare Systems \| Panel Rachael A Callcut M.D., Assoc. Prof. of Surgery, UCSFUCSF	Breast Cancer Genetics: Molecular Tumor Signatures and Hereditary Cancer Tests \| Panel Barbara Cohn Ph.D., Research Dir., Child Health, Public Health Inst.Public Health Inst.	Patient-Specific Cancer Monitoring With Droplet Digital PCR Alex Dobrovic Ph.D., Head, Translational Genomics & Epigenomics, ONJ Cancer Research Inst.Olivia Newton John Cancer Research Inst.	Gastroenterology & the Microbiome Haroldo Magarinos N.D., Naturopathic Physician, BioVital HealthBioVital Health	Emerging Therapeutics Showcase Donato Tedesco Ph.D., Dir. of R&D, CellectaCellecta	Wellness and Aging Showcase Chair: Marvin Singh M.D., Board Member, ABOIM, Clinical Prof., UCSDUCSD
Jan. 23 2:45 P.M.	Investigational Therapeutic for Cardiac Amyloidosis Uma Sinha Ph.D., CSO, Eidos TxEidos Tx	Implementing ML-Based Decision Support in Hospitals & Healthcare Systems \| Panel Brittany Dugger Ph.D., Co-leader, Alzheimer’s Disease, UCDUC Davis	Breast Cancer Genetics: Molecular Tumor Signatures and Hereditary Cancer Tests \| Panel Eleanor E Harris M.D., Prof. & Vice-Chair, Dept. of Radiation Oncology, CWRUCase Western Reserve U.	Patient-Specific Cancer Monitoring With Droplet Digital PCR Hanlee Ji M.D., Prof. & Senior Assoc. Dir., Division of Oncology, StanfordStanford	Pre-Clinical/Clinical Nikole Kimes Ph.D., Founder & CEO, Siolta TxSiolta Tx	Emerging Therapeutics Showcase Peter Cameron Ph.D., Senior Scientist, Caribou BiosciencesCaribou Biosciences	Wellness and Aging Showcase Eric Morgen M.D., COO, BIOAGEBIOAGE
Jan. 23 3:00 P.M.	Break, Exhibition and Networking
Jan. 23 3:30 P.M.	Cardiovascular Proteomics Chair: Peter Ganz M.D., Chief of Cardiology, Zuckerberg SF Gen. HospitalUCSF	Computational Models That Expedite Clinical Diagnostics Chair: Esther L Yuh M.D., Ph.D., Assoc. Prof. of Radiology & Biomedical Imaging, UCSFUCSF	Precision Medicine Leads to Better Fertility Outcomes Aimee Eyvazzadeh M.D., Board Certified OBGYN; Egg WhispererEgg Whisperer	Early Detection Progress And Challenges \| Panel Chair: Alex Aravanis M.D.,Ph.D., CSO & Head of R&D, GRAILGRAIL Inc	Pre-Clinical/Clinical Mary Conrad Assoc. Dir., Microbiology, Axial BiotherapeuticsAxial Biotherapeutics	Emerging Therapeutics Showcase Russell Skibsted Chief Financial Officer, AgeX Tx.AgeX Tx	Health Monitoring Showcase Tim Bauer Ph.D., VP, Head of Clinical Science, EverlywellEverlywell
Jan. 23 3:45 P.M.	Cardiovascular Proteomics Steve Williams M.D., Ph.D., CMO, SomaLogicSomaLogic	Computational Models That Expedite Clinical Diagnostics Eric Kriegstein CEO, RespirixRespirix	Preimplantation Genetic Testing Beyond Recessive Disease Alexander Bisignano CEO, PhosphorusPhosphorus	Early Detection Progress And Challenges \| Panel Ash Alizadeh M.D., Ph.D., Assist. Prof. of Medicine, StanfordStanford	Pre-Clinical/Clinical Jackie Papkoff Ph.D., CSO, Microbiome, Assembly BiosciencesAssembly Biosciences Inc	Emerging Therapeutics Showcase Marcel V Alavi Ph.D., Founder, 712 North712 North Inc	Health Monitoring Showcase Scott Miller Former CEO of Vision Critical; Investor of DataspeaksDataSpeaks
Jan. 23 4:00 P.M.	VC Perspectives on Paradigm-Shifting Opportunities in Cardiovascular Disease \| Panel Chair: Matthias J Kleinz Ph.D., VP, Translational Programs, UPMC EnterprisesUPMC Enterprises	Computational Models That Expedite Clinical Diagnostics Saeed Hassanpour Ph.D., Assist. Prof. of Biomed Data Sci., DartmouthDartmouth	Endometriosis Heather Bowerman Founder & CEO, DotlabDotlab	Early Detection Progress And Challenges \| Panel Raghu Kalluri M.D., Ph.D., Chairman & Prof., Cancer Biology, MD AndersonMD Anderson Johan Skog Ph.D., CSO, Exosome DiagnosticsExosome Diagnostics	Microbiome Showcase Naveen Jain MBA, Founder & CEO, ViomeViome	Emerging Therapeutics Showcase Omar Abudayyeh Ph.D., McGovern Fellow, Massachusetts Inst. of Technology; Co-Founder, Sherlock BiosciencesSherlock Biosciences	Health Monitoring Showcase Michael Brammer Founder & CEO, FamHisFamHis
Jan. 23 4:15 P.M.	VC Perspectives on Paradigm-Shifting Opportunities in Cardiovascular Disease \| Panel Nicholas J Simon Senior Managing Dir., Blackstone Life SciencesBlackstone	Computational Models That Expedite Clinical Diagnostics Aaron Lee M.D., MSCI, Assist. Prof., U. of WashingtonU. of Washington	Clinical Dx Showcase Karen Hunter Cohn Ph.D., VP, Translational Science, CelmatixCelmatix Inc	Early Detection Progress And Challenges \| Panel Jimmy Lin M.D., Ph.D., CSO, FreenomeFreenome	Microbiome Showcase Robert Schlaberg M.D., Ph.D., MPH, CMO, IDbyDNA & Medical Dir., ARUP LabsIDbyDNA	Emerging Therapeutics Showcase Shabnam Tangri Ph.D., CSO, Navigate BioPharmaNavigate BioPharma A Novartis Subsidiary	Wellness and Aging Showcase Joseph J Lamb M.D., Physician/Owner, Personalized Lifestyle Medicine Ctr. by MetagenicPersonalized Lifestyle Medicine Ctr. by Metagenic
Jan. 23 4:30 P.M.	VC Perspectives on Paradigm-Shifting Opportunities in Cardiovascular Disease \| Panel Alexis Ji Ph.D., Partner, Illumina VenturesIllumina Ventures	Data Mining And Visualization Yannis M Paulus M.D., FACS, Assist. Prof., U. of MichiganU. of Michigan	Clinical Dx Showcase Mylene Yao M.D., CEO & Co-Founder, UnivfyUnivfy Inc	Genomic Profiling Showcase Alex Chenchik Ph.D., Pres. & CSO, CellectaCellecta	Microbiome Showcase Malcolm Kendall Senior Dir., Microbiome-Testing Platform, Microbiome InsightsMicrobiome Insights	Clinical & Research Tools Showcase Ana Oromendia Ph.D., Dir., Analytics Product Management, MedidataMedidata Solutions	Wellness and Aging Showcase Cynthia Lawley Ph.D., Population Health, MetabolonMetabolon Inc
Jan. 23 4:45 P.M.	VC Perspectives on Paradigm-Shifting Opportunities in Cardiovascular Disease \| Panel Abraham Bassan VP, Samsara BioCapitalSamsara BioCapital	AI/Data Sciences Showcase Jeremy Orr M.D., MPH, CMO, Medial EarlySignMedial EarlySign	Clinical Dx Showcase Michelle Perugini Ph.D., CEO, Presagen & Life WhispererPresagen	Clinical & Research Tools Showcase Chhaya Shadra Dir. of Product, Data & Informatics, VeranaVerana Health	Investment into the Microbiome \| Panel Chair: Manoj Dadlani CEO, CosmosIDCosmosID Denise Kelly Ph.D., Investment Advisor, Seventure PartnersSeventure Partners	Clinical & Research Tools Showcase Sabah Akrawi Ph.D., Prof., Clinical Pharmacy, King Faisal U.King Faisal U.	Wellness and Aging Showcase Florence Comite M.D., CEO & Founder, Comite PM & HealthComite PM & Health
Jan. 23 5:00 P.M.					Investment into the Microbiome \| Panel Alexander Morgan Ph.D., Principal, Khosla VenturesKhosla Ventures
Jan. 23 5:30 P.M.	Closing

January 24

	Track 1	Track 2	Track 3	Track 4	Track 5	Track 6	Track 7
January 24
Jan. 24 8:00 A.M.	Registration and Networking
Jan. 24 9:00 A.M.	Gene and Cell Editing Methods Jennifer Puck M.D., Prof. of Pediatrics, UCSFUCSF	Data Science For Payers \| Panel Chair: Viet Nguyen M.D., Clinical Informaticist, HL7 Da Vinci ProjectHL7 Da Vinci Project	Fireside Chat Chair: Bonnie Anderson Chairman of the Board & CEO, VeracyteVeracyte	Molecular Tumor Boards Anna Berry M.D., Dir. for Molecular Pathology & Genomics, Swedish CancerSwedish Cancer	Illumina Accelerator Session Amanda Cashin Ph.D., Co-Founder, Head, Illumina AcceleratorIllumina	Clinical Dx Showcase Ed Esplin M.D., Ph.D., Head of Clinical Studies & Medical Information, InvitaeInvitae	Clinical & Research Tools Showcase Klaus Lindpaintner M.D., CSO & CMO, InterVenn BioScienceInterVenn BioScience
Jan. 24 9:15 A.M.	The Genetic And Genomics Of MS Sergio E Baranzini Ph.D., Prof., Neurology, QB3, UCSFUCSF	Data Science For Payers \| Panel Lincoln Smith M.D., Dir., Analytic Enablement, Highmark BCBSHighmark BCBS	Fireside Chat Clifford Hudis M.D., CEO, ASCOASCO	Molecular Tumor Boards Wei Zhang Ph.D., Dir., Ctr. for Cancer Genomics & Prec. Oncology, WFUWake Forest Health	Illumina Accelerator Session Emma Taylor M.D., CEO & Co-founder, Naked BiomeNaked Biome	Clinical Dx Showcase Cecilie Boysen Ph.D., CSO, SomicsMedSomicsMed	Clinical & Research Tools Showcase Chris Apfel M.D., Ph.D., CEO, SageMedicSageMedic
Jan. 24 9:30 A.M.	Genetically Tailored N-of-1 Therapy for an Orphan Disease Julia Vitarello Founder & CEO, Mila’s Miracle FoundationMilas Miracle Foundation	Data Science For Payers \| Panel Frank Opelka M.D., FACS, Medical Dir., Quality & Health Policy, ACSAmerican College of Surgeons	Precision Pharmacotherapy Chair: Mary V Relling PharmD, Chair, Pharma Dept., St. Jude Children’s Research HospitalSt Jude	Molecular Tumor Boards James M Snyder D.O., Neuro-Oncologist, Henry Ford Health SystemHenry Ford Health System	Illumina Accelerator Session Nima Emami Ph.D., CEO, Avail BioAvail Bio	Clinical Dx Showcase Dean Felsher M.D., Ph.D., Prof. of Medicine-Oncology & Pathology, Stanford School of MedicineStanford Medicine	Clinical & Research Tools Showcase Xinyi Zhou Ph.D., Senior Engineer, Triple Ring TechTriple Ring Tech
Jan. 24 9:45 A.M.	Behind the Scenes of the Cancer CAR-T Gene Therapy Ilana Yurkiewicz M.D., Physician & Medical Journalist, StanfordStanford	Data Science For Payers \| Panel Rajiv Bhan Executive Dir., Data Science, AetnaAetna	The VA's Pharmacogenomic Screening Deepak Voora M.D., Assoc. Prof. of Medicine, CAGPM, Duke U.Duke U.	Molecular Tumor Boards Michelle Afkhami M.D., Prof. of Pathology & Med. Dir. Clinical Molecular Diagnostic Lab, City of HopeCity of Hope Compre. Cancer Ctr.	Illumina Accelerator Session Benjamin Yellen Ph.D., Chief Technology Officer, CelldomCelldom	Clinical Dx Showcase Anthony Magliocco M.D., CEO & Pres., Protean BioDiagnosticsProtean BioDiagnostics	Clinical & Research Tools Showcase James Taylor Ph.D., CEO & Co-Founder, Precision NanoSystemsPrecision NanoSystems
Jan. 24 10:00 A.M.	Break, Exhibition and Networking
Jan. 24 10:30 A.M.	Emerging Therapeutics to Dravet Syndrome Jeanne Paz Ph.D., Assoc. Prof. of Neurology, UCSF; Gladstone Inst.Gladstone Inst.s	Healthcare Data Monetization Models Chair: Eric Marton Managing Dir., Three-Sixty Advisory GroupWavemaker 360 Health	Precision Pharmacotherapy continues William E Evans PharmD, Endowed Chair in Pharmacogenomics, St. JudeSt Jude	Molecular Tumor Boards Jens Rueter M.D., Medical Dir., Jackson Lab. Cancer Ctr.The Jackson Laboratory Cancer Ctr.	The Medical Research Gender Gap \| Panel Chair: Anula Jayasuriya M.D., Ph.D., Founder & Managing Dir., EXXclaim CapitalEXXclaim Capital	Emerging Therapeutics Showcase Tooba Cheema Ph.D., Dir. Translational Medicine & Biomarkers, OncorusOncorus	Clinical & Research Tools Showcase Paul Hung Ph.D., CEO, COMBiNATiCOMBiNATi
Jan. 24 10:45 A.M.	Spinal Muscular Atrophy Emerging Therapeutics \| Panel Chair: Jill Jarecki Ph.D., CSO, Cure SMACure SMA	Data Science In Hospitals & Health Systems Sergio E Baranzini Ph.D., Prof., Neurology, QB3, UCSFUCSF	Precision Pharmacotherapy Todd Skaar Ph.D., Prof. of Medicine, Indiana U.Indiana U.	Molecular Tumor Boards Shivaani Kummar M.D., Prof. of Medicine & Radiology, StanfordStanford Health	The Medical Research Gender Gap \| Panel Hadine Joffe M.D., Exec. Dir., Connors Ctr. for Women’s Health & Gender Biology, Brigham & Women’s HospitalHarvard	Emerging Therapeutics Showcase Kent Lloyd Ph.D., DVM, Dir., Mouse Biology Program, UC, DavisUC Davis	Clinical & Research Tools Showcase William Dunbar Ph.D., Founder, Chief Technology Officer, OnteraOntera
Jan. 24 11:00 A.M.	Spinal Muscular Atrophy Emerging Therapeutics \| Panel Frank Bennett Ph.D., SVP of Research, Ionis PharmaIonis Pharma	Data Science In Hospitals & Health Systems Robbie Freeman VP Clinical Innovation, Mount Sinai Health SystemMount Sinai Health System	Precision Pharmacotherapy Andrew Monte M.D., Ph.D., Assoc. Prof., U. of ColoradoU. of Colorado	Molecular Tumor Boards Todd Knepper PharmD, Assist. Member, PM Specialist, Moffitt CancerMoffitt Cancer Ctr.	The Medical Research Gender Gap \| Panel Marcia L Stefanick Ph.D., Prof. of Medicine, StanfordStanford Nisha Parikh M.D., Assoc. Prof. of Medicine, UCSFUCSF Suzanne Steinbaum DO, FACC, FAHA, Pres., SRSHeart; National Spokesperson, Go Red for Women, American Heart Assoc.American Heart Association	Clinical Dx Showcase Antony Newton VP Business Dev., InivataInivata	Clinical & Research Tools Showcase Max Sellman Client Relations Manager, AldevronAldevron
Jan. 24 11:15 A.M.	Spinal Muscular Atrophy Emerging Therapeutics \| Panel David Lennon Ph.D., Pres., AveXisAveXis	AI and Data Sciences Showcase Mark Kiel M.D., Ph.D., Co-Founder & CSO, GenomenonGenomenon	Drug And Disease Induced Phenoconversion Chair: Jacques Turgeon Ph.D., CSO, Tabula Rasa HealthCareTabula Rasa Healthcare	Molecular Tumor Boards Cassie Kline M.D., Pediatric Neuro-Oncologist, UCSFUCSF	Emerging Concepts In Precision Medicine In Racial/Ethnic Populations \| Panel Chair: Ysabel Duron Founder/Pres., The Latino Cancer Inst.The Latino Cancer Inst.	Clinical Dx Showcase Johan Skog Ph.D., CSO, Exosome DiagnosticsExosome Diagnostics	Clinical & Research Tools Showcase Nurul Rutt Head of Corporate & Research Dev., SengenicsSengenics
Jan. 24 11:30 A.M.	Spinal Muscular Atrophy Emerging Therapeutics Q&A	Advancing Precision Health at Indiana University via Omic And Phenotypic Data Integration \| Panel Chair: Don Brown M.D., Founder & CEO, LifeOmicLifeOmic	Drug And Disease Induced Phenoconversion Veronique Michaud BPharm, Ph.D., Adjunct Prof., University of MontrealTabula Rasa Healthcare Todd Skaar Ph.D., Prof. of Medicine, Indiana U. School of MedicineIndiana U.	MTB Software Vendors Brian Piening M.D., Dir., Molecular Pathology, Providence St. Joseph HealthProvidence Portland Medical Ctr.	Emerging Concepts In Precision Medicine In Racial/Ethnic Populations \| Panel Lisa Goldman Rosas Ph.D., MPH, Assist. Prof., Stanford School of MedicineStanford Medicine Laura Fejerman Ph.D., Assoc. Prof., UCSFUCSF Elizabeth Baca M.D., Specialist Leader, Deloitte ConsultingDeloitte Consulting LLP	Clinical Dx Showcase Ruben Bonilla-Guerrero M.D., Medical Dir., Admera HealthAdmera Health	Clinical & Research Tools Showcase Walter Stewart Ph.D., CEO, MedcurioMedcurio Inc
Jan. 24 11:45 A.M.	Gene Therapy for Autoimmune Diseases Rosa Bacchetta M.D., Assoc. Prof. of Pediatrics, StanfordStanford	Advancing Precision Health at Indiana University via Omic And Phenotypic Data Integration \| Panel Milan Radovich Ph.D., Prof. of Surgery, Indiana U. School of MedicineIndiana U.	Precision Pharmacotherapy Stuart Scott Ph.D., Division Head – Pharmacogenomics, Sema4Sema4	MTB Software Vendors James Cole Ph.D., Product Manager, GenomOncologyGenomOncology	Emerging Concepts In Precision Medicine In Racial/Ethnic Populations \| Panel Michael Penn M.D., Ph.D, Managing Dir., Health Equity VenturesHealth Equity Ventures	Clinical Dx Showcase Ofer Sharon M.D., CEO, OncoHostOncoHost	Microbial Profiling Showcase Dan Knights Ph.D., Assoc. Prof., U. of Minnesota; CEO, CoreBiomeCoreBiome
Jan. 24 12:00 P.M.	Break, Exhibition and Networking
Jan. 24 1:00 P.M.	Stem Cell and Gene Therapy for Cystinosis Stephanie Cherqui Ph.D., Assoc. Prof., Dept. of Pediatrics, UCSDUCSD	Embracing Healthcare 4.0 \| Panel Chair: Christian Wolfrum Ph.D., Head of New Business Dev., Siemens HealthineersSiemens Healthineers Sebastian Kronmueller DIPL-PHYS, VP, Molecular Services, Siemens HealthineersSiemens Healthineers	Precision Pharmacotherapy Evidence-based Pharmacogenomics in Psychiatric Care Vicki L Ellingrod PharmD, Assoc. Dean, U. of MichiganU. of Michigan	MTB Software Vendors Ari VanderWalde M.D., Dir. of Research, West Cancer Ctr.West Cancer Ctr. & Research Inst.	The Latest Cancer Treatments for Patients - Future of Patient Care Clifford Hudis M.D., CEO, ASCOASCO	Clinical Dx Showcase Femida Gwadry-Sridhar Ph.D., CEO & Founder, Pulse InfoframePulse Infoframe Inc	AI and Data Sciences Showcase Jeff Green Staff Software Engineer, QIAGENQIAGEN Digital Insights
Jan. 24 1:15 P.M.	FDA Perspective On Gene And Cell Therapies Raj Puri Ph.D., Dir., Division of Cellular & Gene Therapies, FDAFDA	Embracing Healthcare 4.0 \| Panel Dale Newman Business Dev. Executive, Siemens HealthineersSiemens Healthineers Oliver Rinner Ph.D., CEO, Biognosys AG, SwitzerlandBiognosys AG	Precision Pharmacotherapy Elizabeth J Phillips M.D., Prof., Pharma., Pathology, Immunology, VanderbiltVanderbilt U.	Molecular Tumor Board Maurie Markman M.D., Chief Clinical Officer, CTCA HealthCTCA	The Latest Cancer Treatments for Patients - 21st Century Participation in Cancer Trials Craig H Lipset MPH, Principal, Clinical Innovation PartnersClinical Innovation Partners	Clinical Dx Showcase Sungwon Lim Ph.D., CEO/Co-founder, ImpriMedImpriMed	AI and Data Sciences Showcase Michal Warchol Ph.D., Dir., ArdigenArdigen
Jan. 24 1:30 P.M.	FDA Perspective On Gene And Cell Therapies Raj Puri continues	Embracing Healthcare 4.0 \| Panel Kyung Hyun Sung Ph.D., Assoc. Prof., UCLAUCLA	Precision Pharmacotherapy Philip Empey Ph.D., PharmD, Assoc. Dir., Inst. for PM, U. of PittsburghU. of Pittsburgh	Concluding Molecular Tumor Board \| Panel Anna Berry M.D., Dir. for Molecular Pathology & Genomics, Swedish CancerSwedish Cancer	The Latest Cancer Treatments for Patients - Early Detection Richard Wender M.D., Chief Cancer Control Officer, ACSAmerican Cancer Society	Clinical Dx Showcase Towia Libermann Ph.D., Assoc. Prof. of Medicine, HarvardHarvard U.	AI and Data Sciences Showcase Michelle Longmire M.D., CEO & Co-founder, MedableMEDABLE
Jan. 24 1:45 P.M.	Developmental Biology As A Blueprint For Regenerative Medicine Ophir Klein M.D., Ph.D., Prof. & Chief, Divisions of Medical Genetics & Craniofacial Anomalies, UCSFUCSF	Intelligent Medical Imaging \| Panel Chair: Sharmila Majumdar Ph.D., Vice Chair of Research, Radiology, UCSFUCSF	Pharmacogenetic Testing in Healthy Individuals Latha Palaniappan M.D., Prof. of Medicine (Primary Care & Population Health), Stanford U. Medical Ctr.Stanford	Concluding Molecular Tumor Board \| Panel Ari VanderWalde M.D., Dir. of Research, West Cancer Ctr.West Cancer Ctr. & Research Inst.	The Latest Cancer Treatments for Patients - The Consequences of the Technology Explosion Chair: Jennifer Grandis M.D., American Cancer Society Prof., Otolaryngology, UCSFUCSF	Clinical Dx Showcase Aurelija Vaitkuviene M.D.,Ph.D., Senior Researcher, Inst. of Photonics & Nanotech., Vilnius U.Vilnius U.	AI and Data Sciences Showcase Brian Meshkin Managing Dir., Profound Ventures; Executive Chairman & Co-Founder, Bennufit HealthBennufit Health
Jan. 24 2:00 P.M.	Emerging Therapeutics Showcases Michael Olin Ph.D., CSO, OX2 Tx & Assoc. Prof., U. of MinnesotaOX2 Tx	Intelligent Medical Imaging \| Panel Valentina Pedoia Ph.D., Assist. Prof., Radiology & Biomedical Imaging, UCSFUCSF Saikiran Rapaka Ph.D., Head of Strategy, AI & Digital Innovation, Siemens HealthineersSiemens Healthineers	Clinical Dx/ PGx Showcase Kristine Ashcraft B.S., MBA, CEO, YouScriptYouScript	Concluding Molecular Tumor Board \| Panel Maurie Markman M.D., Chief Clinical Officer, CTCA HealthCTCA Wei Zhang Ph.D., Dir., Ctr. for Cancer Genomics & Prec. Oncology, WFUWake Forest Health	The Latest Tech for Cancer Patients - Monitoring for Early Detection, Treatment Response and Recurrence Chair: Vikram Bajaj Ph.D., Managing Dir., Foresite CapitalForesite Capital Daniel Simon MBA, SVP, BioPharma Business Dev., Guardant HealthGuardant Health Inc	Clinical Dx Showcase Robert Meller Assoc. Prof., Morehouse School of MedicineMorehouse School of Medicine	AI and Data Sciences Showcase Lijun Cheng Ph.D., Assist. Prof., College of Medicine, Ohio StateOhio State U. College of Medicine
Jan. 24 2:15 P.M.	Emerging Therapeutics Showcases Jason Christiansen Ph.D., CTO, Boundless BioBoundless Bio Inc	Intelligent Medical Imaging \| Panel Matthew Lungren M.D., Assoc. Dir., AI in Medicine & Imaging Ctr., StanfordStanford Christopher Hess M.D., Ph.D., Prof. & Chairman, Radiology & Biomedical Imaging, UCSFUCSF Abdul Hamid Halabi Global Dir., Healthcare & AI, NVIDIANVIDIA	Clinical Dx/ PGx Showcase Hani El Shawa Ph.D., CEO, Alpha Genomix LabsAlpha Genomix Labs	Concluding Molecular Tumor Board \| Panel Jens Rueter M.D., Medical Dir., Jackson Lab. Cancer Ctr.The Jackson Laboratory Cancer Ctr.	The Latest Tech for Cancer Patients - Molecular Diagnostics - Beyond the Genome Gary Palmer M.D., CMO, TempusTempus	Health Monitoring Showcase Russ Johannesson CEO, GlookoGlooko	AI and Data Sciences Showcase Xiaowu Gai Ph.D., Dir. of Bioinformatics, Ctr. for PM, Children’s Hospital LAChildrens Hospital Los Angeles
Jan. 24 2:30 P.M.	Emerging Therapeutics Showcases Bing Wang Ph.D., CEO, Refuge BiotechRefuge Biotech	Unveiling Cancer Biology Through Multiomics Chair: Fernando Andreu MBA, Chief Business Officer, IndivumedIndivumed	Navigating the Headwinds in the Pharmacogenetics Market Don Rule CEO, Translational SoftwareTranslational Software	Head and Neck Cancer Precision Medicine Jennifer Grandis M.D., ACS; Prof., Otolaryngology, UCSFUCSF	The Latest Tech for Cancer patients - Predicting Treatment Response Matt De Silva Founder & CEO, Notable LabsNotable Labs	Academic & Commercial Accelerators Showcase Chair: Arvind Gupta General Partner, SOSV, Founder, IndieBioIndieBio	Genomic Profiling Showcase Murray Cairns Ph.D., Prof. of Genetics, U. of NewcastleU. of Newcastle
Jan. 24 2:45 P.M.	Winning FDA Approval for GIST Precision Therapy Keith Hanigan Head, US PM, Blueprint MedicinesBlueprint Medicines	Unveiling Cancer Biology Through Multiomics Alexander Hergovich Ph.D., Principal Scientist, Innovate Oncology, EvotecEvotec	Precision Medicine For Obesity Andres Acosta M.D., Ph.D., Prof. of Medicine, Mayo ClinicMayo Clinic	Harnessing EHR Data for Actionable Decision Support Alan Pitt M.D., CMO, CloudMedxCloudMedx	The Latest Tech for Cancer Patients - AI, ML and Big Data Analytics Margaret McCusker M.D., Senior Medical Dir., Flatiron HealthFlatiron Health	Academic & Commercial Accelerators Showcase Gino Segrè Ph.D, Incubator Manager, QB3QB3	Genomic Profiling Showcase Susan Mockus Ph.D., Dir., Product Innovation & Strategic Commerc., Jackson LabThe Jackson Laboratory Cancer Ctr.
Jan. 24 3:00 P.M.	Break, Exhibition and Networking
Jan. 24 3:30 P.M.	How CRISPR Revolutionizes Genomic Medicine \| Panel Chair: Janice Chen Ph.D., Co-Founder & CRO, Mammoth BiosciencesMammoth Biosciences	How the Federated Edge can Improve Medical Research Walter De Brouwer Ph.D., Cofounder & CEO, doc.aidocai	PGx Policymaking In Real Time \| Panel Chair: Jennifer R Leib Founder, Innovation Policy SolutionsInnovation Policy Solutions	A Unique Indigenous Biobank for Omics Research Jennifer Li-Pook-Than Ph.D., Research Assoc., Genetics Dept., StanfordStanford	How Cancer Patients Get What They Need - Clinical Care Chair: Eric Marton Managing Dir., Three-Sixty Advisory GroupWavemaker 360 Health Conrad Vial M.D., Chief Physician Executive of Operations, Sutter HealthSutter Health Maurie Markman M.D., Chief Clinical Officer, CTCA HealthCTCA	Academic & Commercial Accelerators Showcase Paul Yock M.D., Founder & Dir., Byers Ctr. for Biodesign, StanfordStanford Biodesign	Genomic Profiling Showcase Michael Heltzen CEO & Board Member, Cardea BioCardea Bio
Jan. 24 3:45 P.M.	How CRISPR Revolutionizes Genomic Medicine \| Panel Andre Watson Chairman & CEO, LigandalLigandal	AI-Powering Your Clinicians Ahmed El-kalliny Founder & CEO, DNAFeedDNAFeed	PGx Policymaking In Real Time \| Panel Victoria M Pratt Ph.D., Past President, Assoc. for Molecular Pathology, Indiana U.Indiana U.	Integrated Genomic Profiling Expands Clinical Options Gary Palmer M.D., CMO, TempusTempus	How Cancer Patients Get What They Need - Trials, Expanded Access and Reimbursement June Wasser ConsultantConsultant Farid Vij VP oforate Dev., CiitizenCiitizen	Academic & Commercial Accelerators Showcase Kevin V Grimes M.D., Prof., Chemical & Systems Biology; Co-Dir., Stanford SPARKStanford SPARK	AI and Data Sciences Showcase Natasa Przulj Ph.D., ICREA Research Prof., Barcelona Supercomputing Ctr.Barcelona Supercomputing Ctr.
Jan. 24 4:00 P.M.	How CRISPR Revolutionizes Genomic Medicine \| Panel Kiana Aran Ph.D., Co-Founder & CSO of Cardea Bio; Prof. of Med. Diagn. & Tx, KGIKeck Graduate Inst.	Consumer Genomics AI & Data Science: The PRECiZiUM Use-case Ron Ribitzky M.D. Founder, PRECiZiUM project & CEO R&D RibitzkyRandD Ribitzky	PGx Policymaking In Real Time \| Panel Jeffrey N Gibbs J.D., Dir., Hyman, Phelps & McNamara, P.C.Hyman Phelps & McNamara PC Shawn Patrick O’Brien CEO & Board Dir., GenomindGenomind	Cancer Prevention & Screening in the Era of Precision Medicine Richard Wender M.D., Chief Cancer Control Officer, ACSAmerican Cancer Society	How Cancer Patients Get What They Need (Panel Discussion With All Speakers)	Academic & Commercial Accelerators Showcase Kathi Durdon Executive Dir., CNY Biotech AcceleratorCNY Biotech Accelerator	AI and Data Sciences Showcase Peter Cimermancic Ph.D., Pathology Machine Learning Team Lead, VerilyVerily Life Sciences
Jan. 24 4:15 P.M.	How CRISPR Revolutionizes Genomic Medicine \| Panel Jonathan Gootenberg Ph.D., McGovern Fellow, MITMIT Jens-Ole Bock CEO & Co-founder, Board-member, Quality Control Genome Editing, COBO TechCOBO Tech	Machine Learning from Microbiome Metatranscriptomics Predicts Chronic Diseases Guruduth Banavar Ph.D., CTO & Head of AI, ViomeViome	Clinical Implementation Of Polygenic Risk Score \| Panel Chair: Atray Dixit Ph.D., CEO, Coral GenomicsCoral Genomics Katrina Loomis Senior Dir., Head of Emerging Portfolio, Target Sciences, PfizerPfizer	Cutting Edge Precision Oncology at Community Hospital Chair: Anton Yuryev Ph.D., Professional Services Dir., ElsevierElsevier	How Cancer Patients Get What They Need - Panel Discussion - Continued	Academic & Commercial Accelerators Showcase Kara Bortone Ph.D., Sr. Dir., Johnson & Johnson Innovation, JLABSJohnson & Johnson Innovation JLABS	Emerging Therapeutics Showcase Joshua Schiffman M.D., CEO/Co-Founder, PEEL TxPEEL Tx
Jan. 24 4:30 P.M.			Clinical Implementation Of Polygenic Risk Score \| Panel Charles Paulding Ph.D., Dir. Pharmacogenomics, Regeneron PharmaRegeneron Lee-may Chen M.D., Clinical Prof., Dept. of Obstetrics, Gynecology, UCSFUCSF	Cutting Edge Precision Oncology at Community Hospital Francisco Antonio Castillos M.D., Personalized Hematology/Oncology of Wake ForestWakemed	Summary for Patients: So What- Putting It Together Chair: Marty Tenenbaum Ph.D., Founder & Chairman, Cancer CommonsCancer Commons Mika Newton CEO, xCuresxCures	Academic & Commercial Accelerators Showcase Douglas Crawford Ph.D., General Manager, MBC BioLabsMBC BioLabs	Emerging Therapeutics Showcase Jonathan Krive CEO, Co-Founder, AsiaBiomeAsiaBiome
Jan. 24 4:45 P.M.			Clinical Implementation Of Polygenic Risk Score \| Panel Deepak Voora M.D., Assoc. Prof. of Medicine, CAGPM, Duke U.Duke U.		Summary for Patients: The Patient Experience Erika Vial Monteverdi MBA, Executive Dir., Cancer CommonsCancer Commons
Jan. 24 5:00 P.M.					Summary for Patients: Brain, Pancreatic, Ovarian, and Pediatric Perspectives \| Panel James M Snyder D.O., Neuro-Oncologist, Henry Ford Health SystemHenry Ford Health System Carla Grandori M.D., Ph.D., CEO, SEngine PMSEngine PM Conan Kinsey M.D., Ph.D., Prof., Huntsman Cancer Inst., U. of UtahHuntsman Cancer Inst. at the U. of Utah Harvey Cohen M.D., Ph.D., Prof. of Pediatrics, StanfordStanford
Jan. 24 5:15 P.M.					Summary for Patients: Brain, Pancreatic, Ovarian, and Pediatric Perspectives - Continued
Jan. 24 5:30 P.M.	Closing